Earnings Feed
Start Free
Home/Insiders/DZAU VICTOR J
DV
SEC Insider//CIK 0001201252

DZAU VICTOR J

CIK 00012012526 companiesSILVER SPRING, MD
SEC Profile

Transactions

50

Companies

6

Filings

13

CIK

0001201252

Recent Transactions

50 trades
  • Award
    UNITED THERAPEUTICS Corp$UTHR

    Restricted Stock Unit

    2026-07-22+730→ 730 total
  • Award
    UNITED THERAPEUTICS Corp$UTHR

    Stock Option

    2026-07-22+2,300→ 2,300 total
  • Award
    MEDTRONIC INC

    Common Stock

    2014-06-30+399→ 18,610.127 total
  • Award
    PEPSICO INC$PEP

    PepsiCo, Inc. Common Stock

    2013-12-02$83.70/sh+597.372→ 32,592.153 total
  • Award
    PEPSICO INC$PEP

    PepsiCo, Inc. Common Stock

    2013-10-01+1,879.228→ 31,994.782 total
  • Award
    PEPSICO INC$PEP

    PepsiCo, Inc. Common Stock

    2013-09-30+724.554→ 30,115.553 total
  • Award
    ALNYLAM PHARMACEUTICALS, INC.$ALNY

    Stock Option (Right to Buy)

    2013-06-06+15,000→ 15,000 total
  • Award
    MEDTRONIC INC

    Common Stock

    2013-04-29+2,989→ 15,520.311 total
  • Award
    PEPSICO INC$PEP

    PepsiCo, Inc. Common Stock

    2012-10-01+2,123.142→ 29,391 total
  • Award
    PEPSICO INC$PEP

    PepsiCo, Inc. Common Stock

    2012-10-01$70.65/sh+943.624→ 27,267.857 total
  • Award
    PEPSICO INC$PEP

    PepsiCo, Inc. Common Stock

    2012-09-28+674.813→ 26,324.234 total
  • Award
    ALNYLAM PHARMACEUTICALS, INC.$ALNY

    Stock Option (Right to Buy)

    2012-06-21+15,000→ 15,000 total
  • Award
    MEDTRONIC INC

    Common Stock

    2012-04-30+3,665→ 12,224.079 total
  • Award
    PEPSICO INC$PEP

    PepsiCo, Inc. Common Stock

    2011-10-01+2,487.975→ 25,649.421 total
  • Award
    PEPSICO INC$PEP

    PepsiCo, Inc. Common Stock

    2011-09-30+607.156→ 23,161.446 total
  • Award
    ALNYLAM PHARMACEUTICALS, INC.$ALNY

    Stock Option (right to buy)

    2011-06-09+15,000→ 15,000 total
  • Award
    MEDTRONIC INC

    Common Stock

    2011-05-02+3,305→ 8,335.957 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+322.9→ 9,524.62 total
  • Disposition to Issuer
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04$76.01/sh−3,943.942→ 5,000 total
  • Exercise/Conversion
    GENZYME CORP

    Phantom Stock

    2011-04-04−302.06→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Restricted Stock Units

    2011-04-04−2,375→ 0 total
  • Disposition to Issuer
    GENZYME CORP

    Stock Option (right to buy)

    2011-04-04$46.24/sh−18,000→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+455.044→ 8,833.764 total
  • Exercise/Conversion
    GENZYME CORP

    Phantom Stock

    2011-04-04−255.418→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+255.418→ 10,912.982 total
  • Exercise/Conversion
    GENZYME CORP

    Phantom Stock

    2011-04-04−499.363→ 0 total
  • Disposition to Issuer
    GENZYME CORP

    Stock Option (right to buy)

    2011-04-04$45.96/sh−1,010→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+2,375→ 7,375 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+198.394→ 11,318.942 total
  • Disposition to Issuer
    GENZYME CORP

    Stock Option (right to buy)

    2011-04-04$43.90/sh−9,000→ 0 total
  • Disposition to Issuer
    GENZYME CORP

    Stock Option (right to buy)

    2011-04-04$53.47/sh−3,000→ 0 total
  • Disposition from Tender
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04$74.00/sh−2,550→ 0 total
  • Disposition to Issuer
    GENZYME CORP

    Stock Option (right to buy)

    2011-04-04$51.52/sh−7,125→ 0 total
  • Disposition to Issuer
    GENZYME CORP

    Stock Option (right to buy)

    2011-04-04$58.50/sh−14,000→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Phantom Stock

    2011-04-04−263.462→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Phantom Stock

    2011-04-04−504.357→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Phantom Stock

    2011-04-04−322.9→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Phantom Stock

    2011-04-04−198.394→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+367.956→ 9,201.72 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+263.462→ 10,657.564 total
  • Exercise/Conversion
    GENZYME CORP

    Phantom Stock

    2011-04-04−367.956→ 0 total
  • Disposition to Issuer
    GENZYME CORP

    Stock Option (right to buy)

    2011-04-04$58.66/sh−7,500→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Phantom Stock

    2011-04-04−207.566→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+504.357→ 7,879.357 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+499.363→ 8,378.72 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+302.06→ 9,826.68 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+286.546→ 10,113.226 total
  • Exercise/Conversion
    GENZYME CORP

    Phantom Stock

    2011-04-04−455.044→ 0 total
  • Disposition to Issuer
    GENZYME CORP

    Stock Option (right to buy)

    2011-04-04$68.48/sh−7,500→ 0 total
  • Exercise/Conversion
    GENZYME CORP

    Genzyme common stock (GENZ)

    2011-04-04+280.876→ 10,394.102 total

Companies

6

Recent Filings

13

Address

C/O UNITED THERAPEUTICS CORPORATION 1000 SPRING STREET

SILVER SPRING, MD, 20910

View on SEC.gov